CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 174,756	$ 30,294
Restricted cash	3,056	66,196
Patient accounts receivable	268,551	237,596
Prepaid expenses	12,487	8,243
Other current assets	9,278	8,225
Total current assets	468,128	350,554
Property and equipment, net of accumulated depreciation of $98,472 and $96,137	26,477	28,113
Operating lease right of use assets	83,693	84,791
Goodwill	721,049	658,500
Intangible assets, net of accumulated amortization of $9,341 and $7,044	68,251	64,748
Deferred income taxes	20,199	21,427
Other assets	52,287	54,612
Total assets	1,440,084	1,262,745
Current liabilities:
Accounts payable	31,147	31,259
Payroll and employee benefits	109,713	120,877
Accrued expenses	136,659	137,111
Current portion of long-term obligations	11,122	9,927
Current portion of operating lease liabilities	27,465	27,769
Total current liabilities	316,106	326,943
Long-term obligations, less current portion	379,942	232,256
Operating lease liabilities, less current portion	54,926	56,128
Other long-term obligations	8,966	5,905
Total liabilities	759,940	621,232
Commitments and Contingencies—Note 5
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 36,746,554 and 36,638,021 shares issued; and 32,370,345 and 32,284,051 shares outstanding	37	37
Additional paid-in capital	656,266	645,256
Treasury stock, at cost 4,376,209 and 4,353,970 shares of common stock	(255,291)	(251,241)
Accumulated other comprehensive income	0	15
Retained earnings	278,185	246,383
Total Amedisys, Inc. stockholders’ equity	679,197	640,450
Noncontrolling interests	947	1,063
Total equity	680,144	641,513
Total liabilities and equity	$ 1,440,084	$ 1,262,745